The DARC side of GWAS

Blood

Volumn 115, Issue 26, 2010, Pages 5285-5286

  Chanock, Stephen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; DUFFY BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

BLOOD GROUP DUFFY SYSTEM; CLINICAL DECISION MAKING; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; NOTE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT;

EID: 77956512805     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-02-263699     Document Type: Note

References (7)

1. Hirshhorn JN. Genome-wide association studies: illuminating biological pathways. N Engl J Med. 2009;360(17):1699-1701.
2. Hunter DJ, Kraft P. Drinking from the fire hose: statistical issues in genomewide association studies. N Engl J Med. 2007;357(5):436-439. (Pubitemid 47204871)
3. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest. 2008;118(5):1590-1605. (Pubitemid 351632361)
4. Donnelly P. Progress and challenges in genome-wide association studies in humans. Nature. 2008;456(7223):728-731.
5. Chanock S. High marks for GWAS. Nat Genet. 2009;41(7):765-766.
6. Schnabel RB, Baumert J, Barbalic M, et al. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood. 2010;115(26):5289-5299.
7. Iwamoto S, Omi T, Kajii, E Ikemoto S. Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood. 1996;85(3):622-626.